SOLICITATION NOTICE
B -- Data and Biological Specimens of Esophageal Cancer
- Notice Date
- 8/10/2010
- Notice Type
- Presolicitation
- NAICS
- 541380
— Testing Laboratories
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Solicitation Number
- NCI-100179-KM
- Archive Date
- 9/9/2010
- Point of Contact
- Karri L. Mares, Phone: 3014357774, Caren N Rasmussen, Phone: (301) 402-4509
- E-Mail Address
-
maresk@mail.nih.gov, cr214i@nih.gov
(maresk@mail.nih.gov, cr214i@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Contracting Office Address Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd. EPS Suite 600, Room 6070, Rockville, MD, 20852, UNITED STATES Description The National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Nutritional Epidemiology Branch (NEB) plans to procure on a sole source basis data and biological specimens from the GEMINI case- control study of esophageal cancer in Golestan Providence, Iran from the International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. Period of Performance shall be for twelve (12) months from date of award. The Nutritional Epidemiology Branch (NEB), Division of Cancer Epidemiology and Genetics, NCI conducts intramural research in areas related to nutrition and cancer which are aimed at lowering human cancer risk. One focus of NEB research is esophageal cancer, especially in high-risk populations. NEB scientists have performed studies of esophageal cancer in high-risk areas of China for over 25 years. An area of central Asia from the Caspian Sea to northwestern China has been identified as the Central Asian Esophageal Cancer Belt because the population throughout this region is at elevated risk of esophageal cancer. The Western edge of this belt is Golestan Province, in northeastern Iran. This population was studied by the International Agency for Research on Cancer (IARC) in the 1970s, and IARC has recently re-started studies in this region, including a case-control study in Golestan Province. Recruitment for this study has now been completed, and a total of 300 cases and 900 controls have been enrolled. The NEB previously acquired data and biological samples from 300 cases and 600 controls recruited in this study, and now requires the acquisition of similar data and biological samples from the last 300 controls that have now been recruited. This data will aid the NEB in understanding the causes of ESCC in this high risk population and will allow it to make comparisons between high-risk areas in China and the Central Asian Esophageal Cancer Belt. The IARC is the only major research institution conducting population-based studies of esophageal cancer in the Central Asian Esophageal Cancer Belt, so it is the only source for data and biological samples from this area. IARC has a long history of quality research activities, including research in this area of Iran, so the data and samples that they collect will be of high quality and will be comparable to data and samples collected by NEB research studies in China. The comparison of results from these two areas, which are very different geographically, culturally and ethnically, will be a valuable resource for identifying etiologic risk factors for this disease that are important throughout the world. IARC previously provided data and biological samples to NEB from 300 cases and 600 controls in their GEMINI case-control study in Golestan Province ; NEB now requires similar data and samples from the last 300 control subjects in this same study. Obtaining these data and samples is possible only from IARC, which This notice is not a request for competitive quotation. However, if any interested party believes it can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. Capability statements must be received in the contracting office by 11:00 AM EST, on August 25, 2010. For further information, please contact Karri Mares, Contract Specialist via electronic mail at maresk@mail.nih.gov. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. No faxed or emailed capability statements will be accepted. In order to receive an award, contractors must be registered and have valid certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA). Reference: NCI-100179- KM on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/NCI-100179-KM/listing.html)
- Record
- SN02235098-W 20100812/100810235537-7c461a14920f7eec3d102a7c0e5f4c5d (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |